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ABSTRACT
Objectives To perform ﬁne mapping of the PXK locus
associated with systemic lupus erythematosus (SLE) and study
functional effects that lead to susceptibility to the disease.
Methods Linkage disequilibrium (LD) mapping was
conducted by using 1251 SNPs (single nucleotide
polymorphism) covering a 862 kb genomic region on 3p14.3
comprising the PXK locus in 1467 SLE patients and 2377
controls of European origin. Tag SNPs and genotypes
imputed with IMPUTE2 were tested for association by using
SNPTEST and PLINK. The expression QTLs data included three
independent datasets for lymphoblastoid cells of European
donors: HapMap3, MuTHER and the cross-platform eQTL
catalogue. Correlation analysis of eQTLs was performed using
Vassarstats. Alternative splicing for the PXK gene was
analysed on mRNA from PBMCs.
Results Fine mapping revealed long-range LD (>200 kb)
extended over the ABHD6, RPP14, PXK, and PDHB genes on
3p14.3. The highly correlated variants tagged an SLE-
associated haplotype that was less frequent in the patients
compared with the controls (OR=0.89, p=0.00684). A
robust correlation between the association with SLE and
enhanced expression of ABHD6 gene was revealed, while
neither expression, nor splicing alterations associated with
SLE susceptibility were detected for PXK. The SNP allele
frequencies as well as eQTL pattern analysed in the CEU and
CHB HapMap3 populations indicate that the SLE association
and the effect on ABHD6 expression are speciﬁc to
Europeans.
Conclusions These results conﬁrm the genetic association
of the locus 3p14.3 with SLE in Europeans and point to the
ABHD6 and not PXK, as the major susceptibility gene in the
region. We suggest a pathogenic mechanism mediated by
the upregulation of ABHD6 in individuals carrying the SLE-
risk variants.
INTRODUCTION
PXK (PXK domain-containing serine/threonine
kinase) is an ubiquitously expressed protein that
binds to and modulates the plasma membrane Na,
K-ATPase.1 Genetic variation at the PXK gene locus
was associated with the susceptibility to develop sys-
temic lupus erythematosus (SLE) by a genome-wide
association study (GWAS) conducted in European
individuals.2 The SLE-associated variant rs6445975
is located in intron 4 of the PXK gene, and no func-
tional mechanism by which this single nucleotide
polymorphism (SNP), or another variant in LD with
it, affects gene function has been characterised yet.
Moreover, while the association with this locus was
corroborated in SLE3 4 and other autoimmune dis-
eases, such as systemic sclerosis5 and rheumatoid
arthritis in several European populations and north
Indians,6 7 no association has been observed in either
GWAS or single SNP replication studies in Chinese,
Korean, African–American and Finnish popula-
tions.8–15 Apart from genetic heterogeneity observed
for the PXK association, the function of the encoded
kinase remains largely unknown, as well as the patho-
genic pathway where it might take part in.16
In order to conﬁrm and characterise the associ-
ation of PXK in more detail, we performed a ﬁne
mapping of the gene locus and neighbouring
regions in a collection of European SLE samples,
and performed functional analysis of genes in the
3p14.3 region.
METHODS
Patients and controls
After quality control of the data, the study sample
consisted of 1467 patients with SLE and 2377
ethnicity-matched healthy control subjects. A total
of 1118 cases and 1526 controls belong to the
European multicentre collaboration network
BIOLUPUS, comprising individuals from Argentina,
Belgium, Germany, Hungary, Italy, Portugal, Spain
and Sweden. An independent set of 349 cases and
851 Spanish controls recruited at the GENyO in
Granada, Spain, were also included. All patients
fulﬁlled at least four of the American College of
Rheumatology 1982 criteria for the classiﬁcation of
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SLE.17 All participating individuals provided informed consent
for this study. The institutional review boards (IRB) and ethical
committees of each participating organisation approved the
study. Samples with an individual genotyping rate lower than
90%, duplicated, and/or related were excluded. We also
removed individuals with <90% of European ancestry, as esti-
mated by using STRUCTURE V.2.3.318 and 350 ancestry
informative markers (AIMs).
Single-nucleotide polymorphisms (SNPs) selection
and genotyping
From the linkage disequilibrium (LD) structure of the PXK locus
in the HapMap CEU population (data release 27; available at
http://hapmap.ncbi.nlm.nih.gov/), tag SNPs capturing more than
90% of common variation at the gene locus (minor allele fre-
quency greater than or equal to 5%) including 50 kb upstream
and downstream of the gene, at a r2 threshold of greater than or
equal to 0.8, were selected using the tagger algorithm imple-
mented in Haploview V.4.1.19 The SNP rs6445975, previously
reported to be associated with SLE,2 was also genotyped. After
genotyping and quality control of the data, 12 tag SNPs were
used to guide the imputation.
All samples from the BIOLUPUS cohort were genotyped at
the Feinstein Institute for Medical Research (Manhasset, NY)
using a GoldenGate Custom Genotyping Assay and a
BeadXpress Reader from Illumina (San Diego, California).
Additionally, the GENyO samples were genotyped using the
Immunochip Bead Array from Illumina.20
Imputation
Imputation was performed by using IMPUTE2 V.2.2.221 across
a 1.1Mb genomic region (chr3 : 57 800 000–58 900 000)
(GRCh37/hg19) that includes the PXK locus. As reference geno-
types, we used the phased haplotypes from a multipopulation
reference panel from the 1000 Genomes Project Phase 1 (down-
loaded from (http://mathgen.stats.ox.ac.uk/impute/data_
download_1000G_phase1_interim.html) on 11 November
2012).22 Cases and controls were imputed in a single run using
recommended parameters. After imputation, only imputed gen-
otypes with a probability equal to or greater than 0.9, imput-
ation INFO score equal to or greater than 0.5, MAF equal to or
greater than 0.005, genotyping rate equal to or greater than
0.95, and following Hardy–Weinberg equilibrium (p>0.001)
were retained for association analysis.
Statistical analyses
Genetic association and conditional analyses of directly typed
and imputed genotypes were carried out by using SNPTEST
V.2.4.1.23 For single-marker tests, we performed a meta-analysis
adjusting by the country of origin as a covariate. The ‘score’
method implemented in SNPTEST (a missing data likelihood
score test) was used to deal with genotype uncertainty. All SNPs
with a genotype call rate <90% or not in the Hardy–Weinberg
equilibrium (p<0.001) were excluded. The p values were cor-
rected for the number of tests performed by using the false dis-
covery rate (FDR) method implemented in PLINK V.1.07.24
Haplotype analysis was conducted by testing each haplotype
against all others pooled together (1 df) using PLINK.
eQTL analysis
The three independent resources with European eQTLs were
analysed: HapMap3 dataset (109 samples),25 MuTHER (856
twins samples),26 and the cross-platform MRCA/MRCE dataset
(405 and 550 samples for each platform).27 Only cis-eQTLs
within 1 Mb ﬂanking the studied markers and/or annotated
gene transcription start sites were taken into account. Preloaded
eQTL p values were extracted for the 3p14.3 region from each
independent eQTL data resource (10 000 permutations were
applied for correction of each SNP values). Further statistical
analyses, including estimation of correlation between
expression-related and SLE-related values, were performed
using VassarStats (http://vassarstats.net) and PRISM V.6 (http://
www.graphpad.com).
PXK transcripts annotation
The alternative splicing of PXK was analysed by PCR with
primers matching to different exons. Total RNA and genomic
DNA were puriﬁed from peripheral blood mononuclear cells
(PBMC) obtained from 84 healthy donors collected at Uppsala
University Hospital as described elsewhere.28 The PCR products
were puriﬁed from gel using QIAquick Gel extraction kit
(Qiagen), sequenced, and the sequences were deposited to
GenBank with the following accession numbers KF774202,
KF774203 and KF774204. The samples’ DNA was genotyped
for the top 10 associated SNPs (table 1).
RESULTS
Fine mapping of the PXK region revealed extensive LD
We performed an association analysis of SNPs across a 232 kb
genomic region surrounding the PXK locus, in which poly-
morphisms had been previously reported as associated with sus-
ceptibility to develop SLE in Europeans.2 After quality control
of the genotyped and imputed variants, 417 SNPs located in
ABHD6, RPP14, PXK and PDHB genes were tested for associ-
ation adjusting by the country of origin. Meta-analysis of the
PXK region revealed strong long-range LD across and beyond
the PXK locus (ﬁgure 1A). The strongest, single, associated
marker was located within the RPP14 gene (rs6445969,
Pmeta-analysis=6.43×10
−4); however, multiple correlated SNPs
(r2>0.8) also displayed similar association along the neighbour-
ing genes ABHD6, RPP14, PXK and PDHB (table 1, see online
supplementary table S1). The association analysis conditioned
on rs6445969 did not provide evidence in favour of an inde-
pendent association of any other SNP. The previously GWAS
SLE-associated variant rs64459752 was not associated in our
study.
Given the extensive LD across the region, we decided to
verify whether the association was extending beyond the previ-
ously analysed 232 kb region. We analysed genotype data cover-
ing a 862 kb region around the PXK locus, which was available
for the 349 patients and 851 controls from the Spanish cohort.
In total, 1251 SNPs were tested for association with the stron-
gest signal located within the intergenic region ABHD6/RPP14
(rs9857570, P=8.3x10−4) (see online supplementary ﬁgure 1).
Consistent with our initial results, long-range LD was observed
with multiple correlated SNPs displaying similar association
across the region. Only nominal association was observed
upstream of the ABHD6 locus with some SNPs within the
DNASE1L3 gene (0.02< p<0.05). These SNPs were not asso-
ciated after adjusting by the top SNP rs9857570. Therefore, we
concluded that the association was limited to the genomic
region containing the ABHD6, RPP14, PXK and PDHB genes.
Haplotype analysis indicates that the SLE-associated
haplotype is under-represented in patients
Haplotype analysis was performed using a representative and
highly informative subset of SNPs that were in approximate LD
with each other. To generate this set, sliding windows of 50
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SNPs were considered at a time, then pairwise LD between each
pair of SNPs within the window was calculated, and ﬁnally, one
SNP of every pair was removed if the r2 was equal to or greater
than 0.8. A representative set of 48 SNPs was obtained, which
formed ﬁve common haplotypes (frequency >0.05). Only one
haplotype was reliably associated with SLE after testing each
haplotype against all others (ﬁgure 1B). The minor alleles of
rs4681842 and rs7610449 are complete proxies of rs6445969
(r2>0.99), and a minor allele of rs11713310 (r2>0.83)
occurred in this haplotype. The SLE-associated haplotype was
under-represented in the patients with a frequency of 29.7%
compared with the 32.8% observed in the controls, and this
difference was statistically signiﬁcant (p=0.0068, OR 0.89
(0.79–0.99)).
Correlation analysis of eQTLs and SLE association points at
ABHD6 as the only gene in the locus signiﬁcantly affected
by SLE-associated variants
In order to uncover the potential functional mechanism under-
lying the SLE association in the studied locus, we analysed three
independent expression quantitative trait loci (eQTLs) databases
for lymphoblastoid cell lines (LCLs) obtained from donors of
European ancestry (HapMap3, MuTHER and a recent study by
Liang et al).25–27 A 1 Mb distance between the target gene tran-
scription start site and the putative eQTL marker was chosen, as
recommended.29
Preliminary analysis allowed us to identify that DNASE1L3,
ABHD6, RPP14, PXK and PDHB gene expression was potentially
inﬂuenced by SNPs in the studied region on chromosome 3. No
signiﬁcant cis-eQTLs were found for other genes. We compared
the polymorphisms studied in the current SLE genetic association
analysis and those characterised as potential eQTLs in the
HapMap3 project (ﬁgure 2, see online supplementary table S2).
Among those SNPs, signiﬁcant eQTLs were detected only for
ABHD6 and PXK genes. While the majority of eQTL markers for
ABHD6 were associated with SLE, there was only one associated
SNP among the eQTLs for PXK, rs11713310. However, this
polymorphism was also an eQTL for ABHD6 (p=0.01), suggest-
ing a long-distance effect due to extended LD (D’1.0, R2=0.737
between eQTL marker for ABHD6 rs4681677 and rs11713310
Table 1 Association analysis of SNPs on 3p14.3 susceptibility locus (only SNPs displaying a p<0.01 are shown)
SNP
BP position
(hg19)
Allele
A
Allele
B
Imputation
INFO score
MAF
allele A
Cases
MAF
allele A
Controls
p Value
CMH
p Value
Breslow–Day
r2
rs6445969
UCSC
Gene Function
rs4681842 58 292 579 G A 0.99572 0.303 0.331 7.08E-04 0.5668 0.999 RPP14 Intronic
rs4681676 58 299 797 A G 0.99586 0.302 0.330 6.43E-04 0.5672 1 RPP14 Intronic
rs6445969 58 301 336 C T 0.99597 0.302 0.330 6.43E-04 0.5663 1 RPP14 Intronic
rs4681677 58 302 040 A G 0.99704 0.303 0.331 7.08E-04 0.5668 0.999 RPP14 Intronic
rs2056119 58 309 393 A G 0.99704 0.303 0.331 7.08E-04 0.5668 0.999 RPP14/PXK Intergenic
rs6445971 58 314 324 G T 0.99704 0.303 0.331 7.08E-04 0.5668 0.999 RPP14/PXK Intergenic
rs6445971 58 319 958 G A 1 0.304 0.333 7.79E-04 0.5724 0.991 PXK Intronic
rs11713310 58 320 984 G A 0.99978 0.364 0.391 9.34E-04 0.7011 0.761 PXK Intronic
rs6445972 58 321 707 C T 1 0.304 0.332 8.13E-04 0.575 0.993 PXK Intronic
rs9817084 58 326 253 T A 0.99845 0.304 0.332 7.42E-04 0.5427 0.994 PXK Intronic
rs6445975* 58 370 177 G T 0.99992 0.265 0.250 9.49E-02 0.1066 0.155 PXK Intronic
CMH: Cochran-Mantel-Haenszel meta-analysis done after adjusting the association by the country of origin. The correspondent Breslow–Day test for assessing the homogeneity of the
OR is shown. Linkage disequilibrium (shown as r2 values) with the top associated variant rs6445969 (bold) is indicated. Association analysis was conducted by using SNPTEST and the
imputation INFO score obtained after imputation with IMPUTE2 was incorporated in the analysis.
*rs6445975 was previously associated with SLE in GWAS.2
Figure 1 The PXK locus in SLE.
(A) The association analysis of 417
SNPs covering a 232kb genomic region
surrounding the PXK locus. The
strongest association was located
within the RPP14 gene (rs6445969,
Pmeta-analysis=6.43×10
−4); however,
multiple correlated SNPs (r2>0.8) also
displayed similar association along the
neighbouring genes ABHD6, RPP14,
PXK and PDHB reﬂecting long-range
linkage disequilibrium in the region.
(B) Haplotype analysis indicates that
the SLE-associated haplotype is
under-represented in the patients with
a frequency of 29.7% compared to the
32.8% observed in the controls.
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according to the CEU subset of 1000 Genomes data). Three
more eQTLs, rs17059171, rs7643185 and rs13082278, showing
an effect only on the PXK gene were not associated with SLE.
The low r2=0.080 between these markers and rs11713310
argues against their role in the association with SLE. Despite the
location of the top associated SNP rs6445969 in intron of
RPP14, no signiﬁcant eQTLs were found for this gene.
As the number of individuals with European ancestry (CEU)
in the HapMap3 eQTL dataset was rather limited and contained
only 109 samples,25 we decided to verify the results (ﬁgure 3A)
by using two additional high-coverage representative resources
focused on European samples—multiple tissue MuTHER,26 and
the latest highly representative cross-platform eQTL catalogue
published by Liang et al.27 The ABHD6 gene remained the only
gene with positive correlation between SLE association and
eQTL values in all these datasets. Moreover, the increase in
coverage and representation signiﬁcantly improved the ABHD6
gene eQTL values and correlation with SLE association
(R2=0.76 for HapMap3 and R2=0.85 for Liang et al27 dataset)
(ﬁgure 3B). The potential regulatory SNPs according to the
Regulome database30 were more frequent among the markers
characterised both as signiﬁcant for SLE association and ABHD6
expression. Of note, the genetic effect on the PXK levels though
not related to SLE association, was detected in all databases ana-
lysed. No other studied genes showed correlation between SLE
association and expression changes, although we observed
strong eQTLs for DNASE1L3 (ﬁgure 4).
The MuTHER project contains expression data for lympho-
blastoid, adipose and skin tissues obtained from the same indivi-
duals.26 Interestingly, we found that the SNPs associated with
SLE correlated with expression of ABHD6 only in LCLs, but
not in the heterologous adipose or skin tissues (see online sup-
plementary ﬁgure 2). Such correlation detected only in the
highly relevant to immunity lymphoblastoid cells may indirectly
support our claim about the role of ABHD6 in SLE.
Next, in order to exclude alternative splicing that may affect
the gene function signiﬁcantly, but its effect could be missed out
in the expression studies, we characterised all isoforms tran-
scribed from the PXK gene in PBMCs. We detected several tran-
scripts, but found no correlation of any of them with any
genotype or with PXK expression levels (data not shown).
We also veriﬁed if any detrimental non-synonymous SNPs in
the PXK gene were reported in the 1000 Genomes project and
other databases, and if these could be in LD with associated var-
iants that might explain the association of PXK. Only two
nsSNPs with moderate LD (R2=0.7) with SNP rs4681677 were
reported for PXK. Both are, however, predicted to be benign by
SIFTand PolyPhen-2 (see online supplementary table S3).31 32
eQTL analysis supports the population-speciﬁc nature of the
ABHD6-PXK region association with SLE
The genetic association of the PXK region with SLE in
Europeans was not conﬁrmed in either Asians or African–
Americans.8–11 This prompted us to compare the expression
data for Europeans (CEU) and Chinese (CHB) populations avail-
able in HapMap3 dataset. The Chinese eQTL dataset included
45 unrelated Bejing individuals. In contrast with Europeans, we
detected no signiﬁcant eQTLs for ABHD6 and PXK in the
Chinese population data (ﬁgure 4, see online supplementary
table S4). While the strongest eQTL signals located in the pro-
moter of DNASE1L3 were found in both populations, none of
them were associated with SLE, neither in the CEU nor CHB
sets. The eQTL signals for PXK were also signiﬁcant in
Europeans, but not in Chinese, however, as mentioned above,
they are not associated with SLE (ﬁgures 2 and 3). This ﬁnding
allowed us to conclude that changes in ABHD6 gene expression
could be important for SLE risk only in Europeans, and this is
further supported by the lack of an association signal in the
3p14.3 locus with SLE in Chinese GWAS.13
SLE risk alleles are strongly associated with ABHD6
overexpression in LCLs
Further, in order to study the effect of polymorphisms asso-
ciated with SLE on ABHD6 gene expression, we focused on the
top associated SNPs (table 1) and analysed ABHD6 expression
in HapMap3 CEU dataset in more detail. We found that
ABHD6 mRNA level was higher in the samples with the major
allele T of rs6445969, while the minor allele C correlates with
lower transcript levels (p=0.02) (ﬁgure 5A). Moreover, stratiﬁ-
cation by the SLE-associated haplotype made of the minor
alleles of rs6445969 (genotypes for rs4681842 were not avail-
able), rs7610449 and rs11713310 revealed signiﬁcantly lower
gene expression in homozygotes CC-GG-GG compared with
TT-AA-AA (p=0.04) (ﬁgure 5B). Interestingly, the
GWAS-associated SNP rs6445975 whose minor allele is also
present in the SLE-associated haplotype (ﬁgure 1B) does not
correlate with ABHD6 expression (data not shown). These data
indicate that the ABHD6 gene is upregulated in the risk for SLE,
and downregulated in the protective haplotype.
DISCUSSION
We have shown here that a comprehensive analysis of expression
QTL markers may help to pinpoint the culprit gene in large
associated regions with extensive LD. The PXK region is one of
the uncertain genetic associations of SLE due to the lack of rep-
lication in several ethnicities, or of a clear understanding of the
disease pathogenic pathways that might involve the PXK kinase
itself.
The entire locus from DNASE1L3 to PDHB is characterised
by lower recombination rate in comparison to its ﬂanking
regions, thus making it difﬁcult to narrow down the culprit
variant(s) (see online supplementary ﬁgure 1A). Since we
detected neither splicing nor expression level changes, and no
detrimental non-synonymous SNPs in the PXK gene that could
be correlated with SLE association, this prompted us to extend
the functional analysis and include more genes in the region,
DNASE1L3, ABHD6, RPP14, PXK and PDHB, in order to
examine for correlation between polymorphism(s) associated
with SLE susceptibility and gene expression changes.
The gene expression analysis in LCLs using three independent
resources suggests that neither PXK nor RPP14 genes expression
regulation is the mechanism underlying the SLE association with
this locus. Although we could not completely rule out that the
associated variants inﬂuence PXK or RPP14 transcription in a
tissue-speciﬁc manner, we believe that blood cells and LCLs
derived from them represent the most relevant tissues to study
expression of the genes in the locus. Among the tissues and cells
analysed and available at BioGPS (http://biogps.org/
#goto=welcome), high levels of PXK were detected in CD34+
cells, CD19+, CD33+, dendritic cells and CD56+ NK cells,
and in several zones of the brain, while PXK expression in all
other tissues was at a very low, yet detectable level.
Further, among the genes in the 1 Mb region surrounding
PXK, only DNASE1L3 and ABHD6 loci show notable eQTLs in
LCLs from individuals of European ancestry. The linear regres-
sion analysis revealed signiﬁcant correlation between SLE associ-
ation and eQTLs for ABHD6 only. The observed strong eQTL
signals for DNASE1L3 and several eQTLs for PXK and PDHB
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were neither associated with SLE nor lie in LD with other asso-
ciated SNPs (ﬁgures 3 and 4). The initial better correlation of
the SNP rs11713310 with PXK than ABHD6 eQTL in
HapMap3 dataset (ﬁgure 2) was not validated in the other two
independent resources with more individuals included. This
variant was a better eQTL for ABHD6 in MuTHER and the
cross-platform eQTL catalogue.
Moreover, those eQTL signals are common for Europeans
and Chinese, while the association with SLE is rather
population-speciﬁc. The variants that deﬁne the SLE-associated
haplotype identiﬁed in the present study are not polymorphic in
Asians, therefore, we hypothesise that this is the reason why no
association with PXK variants has been replicated in patients
with SLE from this population. Furthermore, the positive
Figure 2 Comparative mapping of
eQTL markers in the PXK locus. The
identical set of SNPs was analysed for
their effect on expression of studied
genes in HapMap3 CEU dataset. The p
values for eQTLs are shown in -log
scale, SNPs associated with SLE are
depicted with red dotted boxes. The
SLE-associated SNP rs11713310 shows
slightly higher effect on PXK gene
comparing with ABHD6 and enclosed
in violet dotted box. Three SNPs
(depicted by arrows) showing the
profound effect on PXK gene
expression are not associated with SLE.
Figure 3 Linear regression analysis
of association with SLE and gene
expression in lymphoblastoid cell lines.
(A) Correlation of SLE-associated
polymorphisms and eQTLs from CEU
HapMap3. p values are presented in –
log scale. ABHD6 is the only gene
characterised with positive correlation
between SLE association and
expression effect. (B) The positive
correlation between ABHD6 expression
and association with SLE is
signiﬁcantly improved when using the
high-coverage cross-platform eQTL
dataset.27 Other studied genes
demonstrated lack of any correlations
between SLE association and eQTLs.
The functionally relevant SNPs are
depicted according to their Regulome
database score,30 shown as diamonds
of decreasing size. The declining order
from 1 to 7 reﬂects the presence of
either a full set of features (1a
contains: eQTL, TF binding, matched
TF motif, matched DNase footprint and
DNase peak) or absence of some of
them or all (7). Many ABHD6 SNPs
have high potential to be functionally
important for gene regulation.
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correlation between ABHD6 expression changes and association
with SLE was detectable in most of the data obtained on LCLs
from European donors, while no signiﬁcant cis-eQTL signals for
ABHD6 in HapMap3 Chinese population were found.
In general, the reason why rs6445975 was not found asso-
ciated in several populations including our own study could be
that it is not a good tag SNP for the disease-associated
haplotype. A ﬁne mapping of the entire locus, including haplo-
type analysis, is recommended for studies in populations with
previously reported lack-of-association instead of a single-SNP
replication strategy.
The ABHD6 gene codes for the abhydrolase domain-containing
protein 6, with a function not fully characterised yet. ABHD6
catalyses the hydrolysis of 2-arachidonylglycerol and takes part
Figure 4 Population-speciﬁc nature
of ABHD6 expression changes in LCLs.
The distribution of eQTL p values for
DNASE1L3, ABHD6 and PXK in
European (CEU) and Chinese (CHB)
HapMap3 datasets shown as
normalised ﬂuorescence expression
values. No signiﬁcant eQTL signals
were detected for ABHD6 in CHB. The
transparent boxes corresponding to the
each gene are shown. The cut-off lines
depicted at each plot correspond to
p=0.05. The three SLE-associated SNPs
rs4681677, rs6445971 and
rs11713310 are depicted as black
diamonds.
Figure 5 Expression of the ABHD6
gene in LCLs. (A) The ABHD6 microarray
expression values for 109 HapMap3
European individuals are shown for the
top associated single nucleotide
polymorphism (SNP) rs6445969. The
major allele T correlates with higher
transcript levels. (B) The upregulation of
ABHD6 gene in a haplotype made of the
major alleles of SNPs rs6445969,
rs7610449 and rs11713310. The median
expression levels, ﬁrst and third quartiles
as well as minimum and maximum
values are shown. Gene expression was
analysed by using Kruskal–Wallis
non-parametric analysis of variance
(ANOVA). Statistical signiﬁcance indicated
by a star corresponds to p=0.02 (A) and
p=0.04 (B). The risk is shown in red
colour, while the protective is in blue.
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in the endocannabinoid signalling regulation.33 Studies on the
protein function have focused on its use as a potential target in
drug addiction therapy.33–35 Besides the proposed neuroregula-
tory function, the detectable expression of ABHD6 in tissues
such as kidney, liver and spleen, indicate the multifunctionality
of this gene’s product. For instance, upregulation of ABHD6 is
detected in Ewing tumours.36 37 Additionally, gene expression
studies of B cells induced by Epstein–Barr virus’ (EBV) EBNA
protein demonstrated that among the top 12 induced genes,
there were two genes from the SLE-associated 3p14.3 locus:
ABHD6 and DNASE1L3.38 Another study showed a rapid
increase of uterine ABHD6 mRNA levels upon stimulation with
oestradiol.39 The EBV is known for its role in a variety of
human pathologies, including several autoimmune diseases.40
The role of oestrogen in the pathogenesis of SLE is widely
acknowledged and supported also by the prevalently female sus-
ceptibility to the disease.41 Thus, the induction of ABHD6 by
EBV and oestrogen is in line with our ﬁnding that enhanced
expression of ABHD6 is associated with increased risk for SLE,
and may further advocate the potential role of ABHD6 in
immunity and SLE aetiology.41 42
Although our data suggest the strong effect of SLE-associated
SNPs on the ABHD6 gene expression, the direct causative
variant(s) is still unknown, and further functional studies are
required to uncover the underlying regulatory mechanisms.
In summary, we demonstrated for the ﬁrst time that the previ-
ous genetic association of PXK variants with SLE might be
attributed to the ABHD6 gene. The association is population-
speciﬁc and supported by the gene upregulation in the risk
haplotype present in Europeans. While those variants are not
polymorphic in Asians, no notable eQTLs were detected in the
locus in the Chinese population either.
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